If you typed Peruvian Clinical Research (PCR) into a search box, you are probably building a CRO or site shortlist for Peru. This article uses only what is public about Peruvian Clinical Research (PCR) (pcr.pe) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.
What Peruvian Clinical Research (PCR) publishes
Peruvian Clinical Research describes itself on its Spanish-language site as a Peruvian company offering clinical research, a licensed drug warehouse (droguería), regulatory consulting and pharmacovigilance. It appears as registered research organization ROIC-117 in the INS register of research organizations (OIC). On ClinicalTrials.gov it is listed as sponsor or collaborator on studies that include a transcranial laser device study in major depressive disorder (NCT05435820, NCT06934135) and a CDC-led influenza vaccine study (NCT06054269).
Peruvian Clinical Research (PCR) vs bioaccess®
| Dimension | Peruvian Clinical Research (PCR) | bioaccess® |
|---|---|---|
| Core focus | Peru clinical operations, droguería (importer/warehouse), PV and regulatory | First-in-human and early feasibility studies for medical devices |
| Geography | Peru (Lima) | Latin America, since 2010 |
| Device FIH track record | No named device first-in-human study found on the public pages reviewed | Published case studies on bioaccessla.com |
| After the trial | See provider site | Live multi-country sanitary registration and in-country holder service |
Where each one fits
If you need a Peru-based team that combines study operations with local import and warehousing of investigational product, PCR’s published services match.
If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including Peruvian Clinical Research (PCR), for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.
For the Peru regulatory path, see CRO in Peru: the First-in-Human CRO on the INS file. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.
Ready to compare a proposal? Request a first-in-human study proposal.
Facts from the Peruvian Clinical Research (PCR) public pages linked above, Peru’s INS public registers and ClinicalTrials.gov, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.